Longevity Health Holdings, Inc.
XAGE
$0.52
-$0.02-3.39%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4,343.29% | -71.88% | -84.96% | -98.65% | -99.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4,343.29% | -71.88% | -84.96% | -98.65% | -99.12% |
| Cost of Revenue | 12,398.04% | 149,066.67% | -- | -- | -- |
| Gross Profit | 2,860.29% | 4,937.50% | -- | -- | -- |
| SG&A Expenses | 42.08% | 54.32% | 49.12% | 48.87% | 7.34% |
| Depreciation & Amortization | -8.69% | -11.94% | -13.15% | -14.20% | -8.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.08% | 35.82% | 6.82% | -3.23% | -43.21% |
| Operating Income | -35.66% | -15.22% | 3.71% | 4.19% | 43.63% |
| Income Before Tax | 40.14% | 54.27% | 51.47% | 33.68% | 49.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 41.14% | 54.88% | 52.02% | 34.28% | 49.54% |
| Earnings from Discontinued Operations | -100.00% | -100.00% | -100.00% | -62.88% | 243.32% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.90% | 51.72% | 49.06% | 32.87% | 71.01% |
| EBIT | -35.66% | -15.22% | 3.71% | 4.19% | 43.63% |
| EBITDA | -36.58% | -15.74% | 3.54% | 4.01% | 44.08% |
| EPS Basic | 43.00% | 63.85% | 93.04% | 93.46% | 96.67% |
| Normalized Basic EPS | 60.24% | 62.50% | 92.60% | 92.67% | 94.57% |
| EPS Diluted | 43.00% | 63.85% | 93.04% | 93.46% | 96.67% |
| Normalized Diluted EPS | 60.24% | 62.50% | 92.60% | 92.67% | 94.57% |
| Average Basic Shares Outstanding | 57.49% | 25.75% | 39.52% | 92.69% | 283.56% |
| Average Diluted Shares Outstanding | 57.49% | 25.75% | 39.52% | 92.69% | 283.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |